Our work has provided evidence for even another detrimental outcome of TLR4 signaling in cancer patients undergoing chemotherapy, i.e. leukemia-inducing chromosomal damage in healthy HSPCs without killing the cells. This evidence concerns the gene TLR4 and cancer.